Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, ottobre 13
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
IRIDEX Corp
IRIX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.8483
-0.0807
-8.69%
Ult. Agg.: Oct 13, 4:27 PM
$0.8203
-0.11
-11.7%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Iridex Financials
Iridex (IRIX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est
Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
Benzinga Newsdesk
PRO
Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 16.67 percent decrease over losses of $(0.06) per share from the same
Benzinga Newsdesk
PRO
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est
Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
Benzinga Newsdesk
PRO
Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per share from the same
Benzinga Newsdesk
Earnings Scheduled For May 19, 2026
Benzinga Insights
PRO
Iridex Sees FY2026 Sales $51.000M-$53.000M vs $56.549M Est.
Iridex (NASDAQ:IRIX) sees FY2026 sales of $51.000 million-$53.000 million vs $56.549 million analyst estimate.
Benzinga Newsdesk